Czech Clinical Trials: Finding the Niches
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of…
Tagged with Clinical Trials
Belgium: Punching Well Above its Weight in Clinical Trials
Despite a population size of only 11.4 million (ninth in Europe), Belgium is the continent’s fifth biggest spender on R&D, behind only Germany,…
The UK: The G7’s Hottest Life Science Investment Destination?
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is to cement the UK’s position as…
Cătălin Radu – General Manager, Bristol Myers Squibb…
Cătălin Radu of Bristol Myers Squibb (BMS) Romania explains how the Celgene acquisition is allowing the company to provide their expertise on a…
Petr Vaculík – Country Manager, PSI CRO Czech Republic
Petr Vaculík, country manager of PSI CRO, a privately owned Swiss clinical research organization (CRO), describes how the number of clinical trials…
Olga Starobová – Medical Director, Medical Management and…
Olga Starobová, medical director of Syneos Health Czech Republic, walks us through the steps put in place to ensure successful synergies during the…
Data – The Catch-All Solution for Costly Clinical Trials?
With clinical trials having become extremely expensive to conduct, industry buzz around the potential of data and artificial intelligence (AI) to…
Brecht Vanneste – Associate VP & Managing Director,…
Brecht Vanneste, associate VP and managing director of MSD in Belgium and Luxembourg, highlights the strategic significance of the affiliate as an…
László Attila – President, Committee of Public Health,…
László Attila, president of the Committee of Public Health of Romania, highlights the Committee’s efforts to mitigate the detrimental effects of…
US FDA New Drug Approvals 2019 Snapshot
Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the FDA’s Center for Drug Evaluation and…
EMA Drugs Approved in 2019
An overview of the types of new medicines recommended for approval by the European Medicines Agency (EMA) in 2019. Made with Visme Infographic Maker…
How Hungary is Maintaining its Clinical Research Reputation
According to Peter Holchacker, director general of Hungary’s Association of Innovative Pharmaceutical Manufacturers (AIPM), “clinical trials…
